Correlation of Subcellular and Intratumoral Photosensitizer Localization with Ultrastructural Features After Photodynamic Therapy

References

• Hayata Y, Kato H. Photodynamic therapy in treatment of early cancer. Photodynamic Therapy: Basic Principle and Clinical Application, BW Henderson, TJ Dougherty. Dekker, New York 1992; 269–278
   Google Scholar
• Manyak MJ, Russo A, Smith PD, Glatstein E. Photodynamic therapy. J Oncol. 1988; 6: 380–391
   Google Scholar
• McCaughan JS, Jr., Brown DG, Hawley PC, . Photo-dynamic therapy: an eight-year experience. Photodynamic Therapy: Basic Principle and Clinical Application, BW Henderson, TJ Dougherty, et al. Dekker, New York 1992; 323–331
   Google Scholar
• Pass HI, Delaney TF. Innovative photodynamic therapy at the National Cancer Institute: intraoperative intracavitary treatment. Photo-dynamic Therapy: Basic Principle and Clinical Application, BW Henderson, TJ Dougherty. Dekker, New York 1992; 287–301
   Google Scholar
• Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer 1992; 28A: 1734–1742
   PubMed Web of Science ®Google Scholar
• Dougherty TJ. Photodynamic therapy. Photochem Photobiol. 1993; 58: 895–900
   PubMed Web of Science ®Google Scholar
• Moan J, Peng Q, Evensen JF, Berg K, Western A, Rimington C. Photosensitizing efficiencies, tumor-and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol. 1987; 46: 713–721
   PubMed Web of Science ®Google Scholar
• Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as cytotoxic agent in photoinactivation of murine tumor. Cancer Res. 1976; 36: 2326–2329
   PubMed Web of Science ®Google Scholar
• Ferraudi G, Arguello GA, Ali H, Van Lier JE. Types I and II sensitized photooxidation of aminoacid by phthalocyanines: a flash photochemical study. Photochem Photobiol. 1988; 47: 657–660
   PubMed Web of Science ®Google Scholar
• Kimel S, Tromberg BJ, Roberts WG, Berns MW. Singlet oxygen generation of porphyrins, chlorins, and phthalocyanines. Photochem Photobiol. 1989; 50: 175–183
   PubMedGoogle Scholar
• Moan J. On the diffusion length of singlet oxygen in cells and tissues. J Photochem Photobiol. B:Biol. 1990; 6: 343–344
   Web of Science ®Google Scholar
• Moan J, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol. 1991; 53: 549–553
   PubMed Web of Science ®Google Scholar
• Peng Q, Moan J. Correlation of distribution of sulfonated aluminum phthalocyanines with their photodynamic effect in tumor and skin of mice bearing CaD2 mammary carcinoma. Br J Cancer 1995; 72: 565–574
   PubMed Web of Science ®Google Scholar
• Gomer CJ. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol. 1991; 54: 1093–1107
   PubMed Web of Science ®Google Scholar
• Moan J, Berg K. Photochemotherapy of cancer: experimental research. Photochem Photobiol. 1992; 55: 931–948
   PubMed Web of Science ®Google Scholar
• Ben-Hur E, Rosenthal I. The phthalocyanines: a new class of mammalian cell photosensitizers with a potential for cancer phototherapy. Int J Radiat Biol. 1985; 47: 145–147
   Google Scholar
• Spikes JD. Phthalocyanines as photosensitizers in biological systems and for photodynamic therapy of tumors. Photochem Photobiol. 1986; 43: 691–700
   PubMed Web of Science ®Google Scholar
• Rosenthal I. Phthalocyanines as photodynamic sensitizers. Photochem Photobiol. 1991; 53: 859–870
   PubMed Web of Science ®Google Scholar
• Bonnett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumor photosensitizers. Biochem J. 1989; 261: 277–280
   PubMedGoogle Scholar
• Bonnett R, Berenbaum MC. Porphyrins as photosensitizers. Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use., G Bock, S Harnett. Wiley, Chichester, UK 1989; 40–59, Ciba Foundation Symposium 146
   Google Scholar
• Spikes JD. New trends in photobiology: chlorins as photosensitizers in biology and medicine. J Photochem Photobiol B:Biol. 1990; 6: 259–274
   PubMed Web of Science ®Google Scholar
• Richter AM, Kelly B, Chow J, et al. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J Natl Cancer Inst. 1987; 79: 1327–1332
   PubMedGoogle Scholar
• Richter AM, Waterfield E, Jain AK, Sternberg ED, Dolphin D, Levy JG. In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives. Photochem Photobiol. 1990; 52: 495–500
   PubMed Web of Science ®Google Scholar
• Villanueva A, Caggiari L, Jori G, Milanesi C. Morphological aspects of an experimental tumor photosensitized with a meso-substituted cationic porphyrin. J Photochem Photobiol B: Biol. 1994; 23: 49–56
   PubMedGoogle Scholar
• Shea CR, Sherwood ME, Flotte TJ, Chen N, Scholz M, Hasan T. Rhodamine 123 phototoxicity in laser-irradiated MGH-U1 human carcinoma cells studied in vitro by electron microscopy and confocal laser scanning microscopy. Cancer Res. 1990; 50: 4167–4172
   PubMedGoogle Scholar
• Morgan AR, Selman SH. New tetrapyrroles for photodynamic therapy. Photodynamic Therapy of Neoplastic Diseases, D Kessel. CRC Press, Boca Raton, FL 1990; 1: 247–262
   Google Scholar
• Winkelman J. The distribution of tetraphenylporphine-sulfonate in the tumor-bearing rat. Cancer Res. 1962; 22: 589–596
   PubMedGoogle Scholar
• Winkelman J, Slater G, Grossman J. The concentration in tumor and other tissues of parentally administered tritium and 14C-labeled tetraphenylporphinesulfonate. Cancer Res. 1967; 27: 2060–2064
   PubMed Web of Science ®Google Scholar
• Kessel D, Thompson P, Saatio K, Nantwi KD. Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine. Photochem Photobiol. 1987; 45: 787–790
   PubMed Web of Science ®Google Scholar
• Berg K, Bommer JC, Winkelman JW, Moan J. Cellular uptake and relative efficiency in cell inactivation by photoactivated sulfonated meso-tetraphenylporphines. Photochem Photobiol. 1990; 52: 775–781
   PubMedGoogle Scholar
• Berenbaum MC, Akande SL, Bonnett R, et al. meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumor photosensitizers with favourable selectivity. Br J Cancer 1986; 54: 717–725
   PubMed Web of Science ®Google Scholar
• Jacobsen PB, Moan J. In vitro uptake and photodynamic action of tetra(3-hydroxyphenyl)porphyrin in cell. Photosensitization, G Moreno, RH Pottier, TG Truscott. Springer, Berlin 1988; H15: 383–385, NATO ASI Series
   Google Scholar
• Peng Q, Moan J, Nesland JM, Evensen JF, Kongshaug M, Rimington C. Localizing and photosensitizing mechanism by tetra(3-hydroxyphenyl)porphin in vivo on human malignant melanoma xenografts in athymic nude mice. Lasers Med Sci. 1990; 5: 399–409
   Google Scholar
• Malik Z, Djaldetti M. 5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced friend erythroleukaemic cells. Cell Differ. 1979; 8: 223–233
   PubMedGoogle Scholar
• Malik Z, Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer 1987; 56: 589–595
   PubMed Web of Science ®Google Scholar
• Bech ø, Peng Q, Berg K, Moan J. Photosensitization of tumor cells in vitro and in vivo using endogenous porphyrins induced with exogenous 5-aminolevulinic acid. Photodynamic Therapy and Biomedical Lasers, P Spinelli, M Dal Fante, R Marchesini. Elsevier Science, Amsterdam 1992; 521–525
   Google Scholar
• Bedwell J, MacRobert AJ, Phillips D, Bown SG. Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumor model. Br J Cancer 1992; 65: 818–824
   PubMed Web of Science ®Google Scholar
• Berg K, Peng Q, Nesland JM, Moan J. Cellular response to photodynamic therapy. SPIE 1993; 2078: 278–285
   Google Scholar
• Peng Q, Moan J, Warloe T, Nesland JM, Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer 1992; 52: 433–443
   PubMed Web of Science ®Google Scholar
• Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principle and present clinical experience. J Photochem Photobiol B:Biol. 1990; 6: 143–148
   PubMed Web of Science ®Google Scholar
• Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinical useful photosensitizer for photodynamic therapy. J Photochem Photobiol B:Biol. 1992; 14: 275–292
   PubMed Web of Science ®Google Scholar
• Winkelman J. Intracellular localization of 'hematoporphyrin' in a transplanted tumor. J Natl Cancer Inst. 1961; 27: 1369–1377
   PubMedGoogle Scholar
• Willingham MC, Pastan I. The visualization of fluorescent protein in living cells by video intensification microscopy (VIM). Cell 1978; 13: 501–507
   PubMed Web of Science ®Google Scholar
• Brakenhoff GJ, van der Voort HTM, van Spronsen EA, Linnemans WAM, Nanninga N. Three-dimensional chromatin distribution in neuroblastoma nuclei shown by confocal scanning laser microscopy. Nature 1985; 317: 748–749
   PubMed Web of Science ®Google Scholar
• McConkey DJ, Orrenius S. Signal transduction pathways to apoptosis. Trends Cell Biol. 1994; 4: 370–374
   PubMedGoogle Scholar
• White JG, Amos WB, Fordham M. An evaluation of confocal versus conventional imaging of biological structures by fluorescence light microscopy. J Cell Biol. 1987; 105: 41–48
   PubMed Web of Science ®Google Scholar
• Peng Q, Moan J, Farrants G, Danielsen HE, Rimington C. Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. Cancer Lett. 1991; 58: 17–27
   PubMed Web of Science ®Google Scholar
• Peng Q, Farrants GW, Madslien K, Bommer JC, Moan J, Danielsen HE, Nesland JM. Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line. Int J Cancer 1991; 49: 290–295
   PubMed Web of Science ®Google Scholar
• Woodburn KW, Vardaxis NJ, Hill JS, Kaye AH, Phillips DR. Subcellular localization of porphyrins using confocal laser scanning microscopy. Photochem Photobiol. 1991; 54: 725–732
   PubMed Web of Science ®Google Scholar
• Peng Q, Danielsen HE, Moan J. Application of confocal laser scanning microscopy for fluorescence detection of photosensitizing fluorophores in neoplastic cells and tissues. SPIE 1993; 2083: 71–82
   Google Scholar
• Moan J, Johannessen JV, Christensen T, Espevik T, McGhie JB. Porphyrin-sensitized photoinactivation of human cells in vitro. Am J Pathol. 1982; 109: 184–192
   PubMed Web of Science ®Google Scholar
• Berns MW, Dahlman A, Johnson F, et al. In vitro cellular effects of hematoporphyrin derivative. Cancer Res. 1982; 42: 2325–2329
   PubMed Web of Science ®Google Scholar
• Coppola A, Viggiani E, Salzarulo L, Rasile G. Ultrastructural changes in lymphoma cells treated with hematoporphyrin and light. Am J Pathol. 1980; 99: 175–192
   PubMed Web of Science ®Google Scholar
• Peng Q, Evensen JF, Rimington C, Moan J. A comparison of different photosensitizing dyes with respect to uptake by C3H-tumors and tissues of mice. Cancer Lett. 1987; 36: 1–10
   PubMedGoogle Scholar
• Malik Z, Babushkina T, Shafran M, Nordenberg Y, Mamet R., Schoenfeld N. Induction of protoporphyrin biosynthesis and photodynamic inactivation of B16 melanoma cells. SPIE 1993; 2078: 355–362
   Google Scholar
• Chan WS, Svensen R, Phillips D, Hart IR. Cell uptake, distribution and response to aluminum sulphonated phthalocyanine, a potential anti-tumor photosensitizer. Br J Cancer 1986; 53: 255–263
   PubMed Web of Science ®Google Scholar
• Paquette B, Ali H, Langlois R, van Lier J. Biological activities of phthalocyanines, VIII: cellular distribution in V-79 Chinese hamster cells and phototoxicity of selectively sulfonated aluminum phthalocyanines. Photochem Photobiol. 1988; 47: 215–220
   PubMedGoogle Scholar
• Moan J, Berg K, Kvam E, . Intracellular localization of photosensitizers. Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use., G Bock, S Harnett, et al. Wiley, Chichester, UK 1989; 95–111, Ciba Foundation Symposium 146
   Google Scholar
• Ben-Hur E, Green M, Prager A, Kol R, Rosenthal I. Phthalocyanine photosensitization of mammalian cells: biochemical and ultrastructural effects. Photochem Photobiol. 1987; 46: 651–656
   PubMed Web of Science ®Google Scholar
• Berg K, Moan J. Mitotic inhibition by phenylporphines and tetrasulfonated aluminum phthalocyanine in combination with light. Photochem Photobiol. 1992; 56: 333–339
   PubMed Web of Science ®Google Scholar
• Dubbelman TMAR, de Bruijne AW, van Seveninck J. Photodynamic effects of protoporphyrin on red blood cell deformability. Biochem Biophys Res Commun. 1977; 77: 811–817
   PubMedGoogle Scholar
• Oseroff AR, Ohuoha D, Ara G, McAuliffe D, Foley J, Cincotta L. Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells. Proc Natl Acad Sci. 1986; 85: 9729–9733
   Google Scholar
• Bachowski GJ, Pintar TJ, Girotti AW. Photosensitized lipid peroxidation and enzyme inactivation by membrane-bound merocyanine 540: reaction mechanisms in the absence of ascorbate. Photochem Photobiol. 1991; 53: 481–491
   PubMedGoogle Scholar
• Valenzeno DP. Photomodification of biological membranes with emphasis on singlet oxygen mechanism. Photochem Photobiol. 1987; 46: 147–160
   PubMed Web of Science ®Google Scholar
• Moan J, Christensen T. Photodynamic effects on human cells exposed to light in the presence of hematoporphyrin: localization of the active dye. Cancer Lett. 1981; 11: 209–214
   PubMedGoogle Scholar
• Berg K, Bommer JC, Moan J. Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy: a study on the relative efficiencies of photoinactivation. Photochem Photobiol. 1989; 49: 587–594
   PubMed Web of Science ®Google Scholar
• Spikes JD, Bommer JC. Zinc tetrasulphophthalocyanine as a photodynamic sensitizer for biomolecules. Int J Radiat Biol. 1986; 50: 41–45
   Web of Science ®Google Scholar
• Robinson RS, Robert AJ, Campbell ID. Photooxidation effects on β-hydroxybutyrate dehydrogenase: studies of membrane fragments and intact mitochondria. Photochem Photobiol. 1987; 45: 231–234
   PubMed Web of Science ®Google Scholar
• Langlois R, Ali H, Brasseur N, Wagner JR, van Lier JE. Biological activities of phthalocyanines-IV: type II sensitized photooxidation of L-tryptophan and cholesterol by sulfonated phthalocyanines. Photochem Photobiol. 1986; 44: 117–123
   PubMed Web of Science ®Google Scholar
• Deuticke B, Henseleit U, Haest CWM, Heller KB, Dubbelman TMAR. Enhancement of transbilayer mobility of a membrane lipid probe accompanies formation of membrane leaks during photodynamic treatment of erythrocytes. Biochim Biophys Acta. 1989; 982: 53–61
   PubMedGoogle Scholar
• Bachowski GJ, Ben-Hur E, Girotti AW. Phthalocyanine-sensitized lipid peroxidation in cell membranes: use of cholesterol as a probe of primary photochemistry. Photochem Photobiol. 1990; 51: 64S
   Google Scholar
• Girotti AW. Photodynamic lipid peroxidation in biological systems. Photochem Photobiol. 1990; 51: 497–509
   PubMed Web of Science ®Google Scholar
• Ben-Hur E, Fujihara T, Suzuki F, Elkind MM. Genetic toxicology of the photosensitization of Chinese hamster cells by phthalocyanines. Photochem Photobiol. 1987; 45: 227–230
   PubMedGoogle Scholar
• Ramakrishnan N, Clay ME, Xue LY, Evans HH, Rodriguez-Antunez A, Oleinick NL. Induction of DNA-protein cross-links in Chinese hamster cells by the photodynamic action of chloroaluminum phthalocyanine and visible light. Photochem Photobiol. 1988; 48: 297–303
   PubMed Web of Science ®Google Scholar
• Kvam E, Moan J. A comparison of three photosensitizers with respect to efficiency of cell inactivation, fluorescence quantum yield and DNA strand breaks. Photochem Photobiol. 1990; 52: 769–773
   PubMedGoogle Scholar
• Moan J, Kvam E, Hovig E, Berg K. Effects of PDT on DNA and chromosomes. Photobiology, E Riklis. Plenum, New York 1991; 821–829
   Google Scholar
• Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR, Oleinick NL. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 1991; 51: 5993–5996
   PubMed Web of Science ®Google Scholar
• Agarwal ML, Larkin HE, Zaidi SIA, Mukhtar H, Oleinick NL. Phospholipase activation triggers apoptosis in photo-sensitized mouse lymphoma cells. Cancer Res. 1993; 53: 5897–5902
   PubMed Web of Science ®Google Scholar
• Henderson BW, Dougherty TJ. How does photodynamic therapy work?. Photochem Photobiol. 1992; 55: 145–157
   PubMed Web of Science ®Google Scholar
• Kongshaug M. Minireview: distribution of tetrapyrrole photosensitizers among human plasma proteins. Int J Biochem. 1992; 24: 1239–1265
   PubMedGoogle Scholar
• Kessel D, Woodburn K. Biodistribution of photosensitizing agents. Int J Biochem. 1993; 25: 1377–1383
   PubMedGoogle Scholar
• Berg K, Bommer JC, Moan J. Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy: cell uptake studies. Cancer Lett. 1989; 44: 7–15
   PubMed Web of Science ®Google Scholar
• Allison BA, Pritchard PH, Richter AM, Levy JG. The plasma distribution of benzoporphyrin derivative and the effect of plasma lipoproteins on its biodistribution. Photochem Photobiol. 1990; 52: 501–507
   PubMed Web of Science ®Google Scholar
• Ginevra F, Biffanti S, Pagnan A, Biolo R, Reddi E, Jori G. Delivery of the tumor photosensitizer Zn(II)-phthalocyanine to serum proteins by different liposomes: studies in vitro and in vivo. Cancer Lett. 1990; 49: 59–65
   PubMedGoogle Scholar
• Jori G, Reddi E. Strategies for tumor targeting by photodynamic sensitizers. Photodynamic Therapy of Neoplastic Disease, D Kessel. CRC Press, Boca Raton, FL 1990; 2: 117–130
   Google Scholar
• Jori G, Reddi E. The role of lipoproteins in the delivery of tumor-targeting photosensitizers. Int J Biochem. 1993; 25: 1369–1375
   PubMedGoogle Scholar
• Kongshaug M, Rimington C, Evensen JF, Peng Q, Moan J. Hematoporphyrin diethers-V: plasma protein binding and photosensitizing efficiency. Int J Biochem. 1990; 22: 1127–1131
   PubMedGoogle Scholar
• Reddi E, Zhou C, Biolo R, Menegaldo E, Jori G. Liposome- or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumors, 1: pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer 1990; 61: 407–411
   PubMed Web of Science ®Google Scholar
• Barel A, Jori G, Perin A, Romandini P, Pagnan A, Biffanti S. Role of high-, low- and very-low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo. Cancer Lett. 1986; 32: 145–150
   PubMed Web of Science ®Google Scholar
• Reddi E, Castro LO, Biolo R, Jori G. Pharmacokinetic studies with zinc(II)-phthalocyanines in tumor-bearing mice. Br J Cancer 1987; 56: 597–600
   PubMedGoogle Scholar
• Mazière JC, Morliere P, Santus R. The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumors. J Photochem Photobiol B:Biol. 1991; 8: 351–360
   PubMedGoogle Scholar
• Lombardi P, Norata G, Maggi FM, et al. Assimilation of LDL by experimental tumors in mice. Biochim Biophys Acta. 1989; 1003: 301–306
   PubMed Web of Science ®Google Scholar
• Vitols S, Söderberg-Reid K, Masquelier M, Bjostrom B, Peterson C. Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells: in vitro and in vivo studies of a drug-lipoprotein complex. Br J Cancer 1990; 62: 724–729
   PubMed Web of Science ®Google Scholar
• Zhou C, Milanesi C, Jori G. An ultrastructural comparative evaluation of tumors photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins. Photochem Photobiol. 1988; 48: 487–492
   PubMedGoogle Scholar
• Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987; 47: 3039–3051
   PubMed Web of Science ®Google Scholar
• Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 1987; 6: 559–594
   PubMed Web of Science ®Google Scholar
• Peavy GM, Krasieva TB, Tromberg BJ. Eusantos ED, Berns MW. Variation in the distribution of a phthalocyanine photosensitizer in naturally occurring tumors of animals. Photochem Photobiol B:Biol. 1995; 271–275
   PubMedGoogle Scholar
• Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol. 1988; 133: 95–109
   PubMed Web of Science ®Google Scholar
• Dvorak HF. Tumors: wounds that do not heal, similarities between tumor stroma generation and wound healing. New Engl J Med. 1986; 31: 1650–1659
   Google Scholar
• Peng Q, Nesland JM, Moan J, Evensen JF, Kongshaug M, Rimington C. Localization of fluorescent Photofrin II and aluminum phthalocyanine tetrasulfonate in transplanted human malignant tumor LOX and normal tissues of nude mice using highly light-sensitive video intensification microscopy. Int J Cancer 1990; 45: 972–979
   PubMed Web of Science ®Google Scholar
• Peng Q, Moan J, Nesland JM, Rimington C. Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts. Int J Cancer 1990; 46: 719–726
   PubMed Web of Science ®Google Scholar
• Dougherty T. Photosensitization therapy and detection of malignant tumors. Photochem Photobiol. 1987; 45: 879–890
   PubMed Web of Science ®Google Scholar
• Zhou C. Mechanisms of tumor necrosis induced by photodynamic therapy. J Photochem Photobiol B:Biol. 1989; 3: 299–318
   PubMedGoogle Scholar
• Henderson BW, Farrell G. Possible implications of vascular damage for tumor cell inactivation in vivo: comparison of different photosensitizer. Photodynamic Therapy: Mechanisms, TJ Dougherty. SPIE, Washington, DC 1989; 1065: 2–10
   Google Scholar
• Milanesi C, Zhou C, Biolo R, Jori G. Zn(II)-phthalocyanine as a photodynamic agent for tumors, II: studies on the mechanism of photosensitized tumor necrosis. Br J Cancer 1990; 61: 846–850
   PubMedGoogle Scholar
• Berenbaum MC, Hall GW, Hoyes AD. Cerebral photosensitization by hematoporphyrin derivative: evidence for an endothelial site of action. Br J Cancer 1986; 53: 81–89
   PubMed Web of Science ®Google Scholar
• Chandhuri K, Keck RW, Selman S. Morphological changes of tumor microvasculature following hematoporphyrin derivative sensitizer photodynamic therapy. Photochem Photobiol. 1987; 46: 823–827
   PubMed Web of Science ®Google Scholar
• Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, Dougherty TJ. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 1985; 45: 572–576
   PubMed Web of Science ®Google Scholar
• Henderson BW, Fingar VH. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 1987; 47: 3110–3114
   PubMed Web of Science ®Google Scholar
• Henderson BW, Fingar VH. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem Photobiol. 1989; 49: 299–304
   PubMed Web of Science ®Google Scholar
• Nelson JS, Liaw LH, Berns MW. Tumor destruction in photodynamic therapy. Photochem Photobiol. 1987; 46: 829–835
   PubMed Web of Science ®Google Scholar
• Nelson JS, Liaw LH, Orenstein A, Roberts WG, Berns MW. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin and phthalocyanine. J Natl Cancer Inst. 1988; 80: 1599–1605
   PubMedGoogle Scholar
• Selman SH, Kreimer-Birnbaum M, Klauning JE, Goldblatt PJ, Keck RW, Britton S. Blood flow in transplanted bladder tumors treated with hematoporphyrin derivative and light. Cancer Res. 1984; 44: 1924–1927
   PubMed Web of Science ®Google Scholar
• Star WM, Marijnissen HPA, van den Berg-Blok AE, Versteeg JAC, Franken KAP, Reinhold HS. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 1986; 46: 2532–2540
   PubMed Web of Science ®Google Scholar
• Tromberg BJ, Orenstein A, Kimel S, et al. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem Photobiol. 1990; 52: 375–385
   PubMedGoogle Scholar
• Fingar FH, Wieman TJ, Wiehle SA, Cerrito PB. The role of microvascular damage in photodynamic therapy; the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 1992; 52: 4914–4921
   PubMed Web of Science ®Google Scholar
• Franken NAP, Vrensen GJFM, van Delft JL, et al. Early morphological changes induced by photodynamic therapy in amelanotic Greene melanoma implanted in the anterior eye chamber of rabbits. Lasers Med Sci. 1988; 3: 27–34
   Google Scholar
• Selman SH, Keck RW, Klauning JE, Kreimer-Birnbaum M, Goldblatt PJ, Britton SL. Acute blood flow changes in transplantable FANFT-induced urothelial tumors treated with hematoporphyrin derivative and light. Surg Forum 1983; 34: 676–678
   Google Scholar
• Ben-Hur E. Mechanisms of blood flow stoppage by photodynamic therapy. Spectrum. 1990; 3: 3–4
   Google Scholar
• Ben-Hur E, Orenstein A. The endothelium and red blood cells as potential targets in PDT-induced vascular stasis. Int J Radiat Biol. 1991; 60: 293–301
   PubMed Web of Science ®Google Scholar
• Ben-Hur E, Dubbelman TMAR, van Stevenick J. Phthalocyanine-induced photodynamic changes of cytoplasmic free calcium in Chinese hamster cells. Photochem Photobiol. 1991; 54: 163–166
   PubMedGoogle Scholar
• Yonuschot G. Early increase in intracellular calcium during photodynamic permeabilization. Free Read Biol Med. 1991; 11: 307–317
   PubMedGoogle Scholar
• Foster TH, Primavera MC, Marder VJ, Hilf R, Sporn LA. Photosensitized release of von Willebrand Factor from cultured human endothelial cells. Cancer Res. 1991; 51: 3261–3266
   PubMed Web of Science ®Google Scholar
• Peng Q, Moan J, Nesland JM. An ultrastructural evaluation of CaD2 mouse mammary carcinoma after photodynamic therapy with meso-tetra(hydroxyphenyl)porphyrin (m-THPP) or its corresponding chlorin (m-THPC). SPIE 1994; 2329: 281–290
   Google Scholar
• Ris HB, Altermatt HJ, Indebitzi R, et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer 1991; 64: 1116–1120
   PubMed Web of Science ®Google Scholar
• Reed MWR, Wieman TJ, Doak KW, Pietsch K, Schuschke DA. The microvascular effects of photodynamic therapy: evidence for a possible role of cyclooxygenase products. Photochem Photobiol. 1989; 50: 419–423
   PubMed Web of Science ®Google Scholar
• Kerdel FA, Soter NA, Lim HW. In vivo mediator release and degranulation of mast cells in hematoporphyrin derivative-induced phototoxicity in mice. J Invest Dermatol. 1987; 88: 277–280
   PubMed Web of Science ®Google Scholar
• He D, Soter NA, Lim HW. The later phase of hematoporphyrin derivative-induced phototoxicity in mice: release of histamine and histologic changes. Photochem Photobiol. 1989; 50: 91–95
   PubMed Web of Science ®Google Scholar
• Choop M. Glasberg MR, Riddle JM, Hetzel FM, Welch KMA. Photodynamic therapy of normal cerebral tissue in the cat: a noninvasive model for cerebrovascular thrombosis. Photochem Photobiol. 1987; 46: 103–108
   PubMedGoogle Scholar
• Henderson BW, Dougherty TJ, Malone PB. Studies on the mechanism of tumor destruction by photoradiation therapy. Porphyrin Localization and Treatment of Tumors, DR Doiron, CJ Gomer. Liss, New York 1984; 601–612
   Google Scholar
• Klauning JE, Selman SH, Shulok JR, Schsfer PJ, Britton SL, Goldblatt PJ. Morphological studies on bladder tumors treated with hematoporphyrin derivative photo-chemotherapy. Am J Pathol. 1985; 119: 236–243
   PubMedGoogle Scholar
• Gomer CJ, Rucker N, Ferrario A, Murphree AL. Cellular and molecular evaluation of photodynamic therapy. Lasers Med Sci. July, 1988; 99, Abstracts lssue
   Google Scholar
• Bugelski P, Porter C, Dougherty T. Autoradiographic distribution hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res. 1981; 41: 4606–4612
   PubMed Web of Science ®Google Scholar
• Carpenter RJ, Ryan RJ, Neel HB, Sanderson DR. Tumor fluorescence with hematoporphyrin derivative. Ann Otol. 1977; 86: 661–666
   Google Scholar
• Musser DA, Wagner JM, Datta-Gupta N. The interaction of tumor localizing porphyrins with collagen and elastin. Res Commun Chem Pathol Pharmacol. 1982; 2: 251–259
   Google Scholar
• Korbelik M, Krosl G, Chaplin DJ. Photofrin uptake by murine macrophages. Cancer Res. 1991; 51: 2251–2255
   PubMedGoogle Scholar
• Korbelik M, Krosl G, Olive PL, Chaplin DJ. Distribution of Photofrin between tumors and tumor associated macrophages. Br J Cancer 1991; 64: 508–512
   PubMedGoogle Scholar
• Korbelik M. Distribution of disulfonated and tetrasulfonated aluminum phthalocyanine between malignant and host cell populations of a murine fibrosarcoma. J Photochem Photobiol B:Bioi. 1993; 20: 173–181
   PubMedGoogle Scholar
• Evans S, Matthews W, Perry R, Frankel D, Norton J, Pass HI. Effects of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl Cancer Inst. 1990; 82: 34–39
   PubMed Web of Science ®Google Scholar
• Bellnier DA. Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α. J Photochem Photobiol B:Biol. 1991; 8: 203–210
   PubMedGoogle Scholar
• Schumaker BP, Hetzel FW. Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem Photobiol. 1987; 46: 899–901
   PubMedGoogle Scholar
• Yamamoto K, Kawanishi S. Oxidation of specific SH groups of mitochondria by photodynamic action of hematoporphyrin: relevance to uncoupling of oxidative phosphorylation. Biochem Pharmacol. 1991; 42: 1087–1092
   PubMedGoogle Scholar
• Marshall JF, Chan WS, Hart IR. Effect of photodynamic therapy on anti-tumor immune defenses: comparison of the photosensitizers hematoporphyrin derivative and chloro-aluminum sulfonated phthalocyanine. Photochem Photobiol. 1989; 49: 627–632
   PubMed Web of Science ®Google Scholar
• Jolles C, Ott MJ, Straight RC, Lynch DH. Systemic immunosuppression induced by peritoneal photodynamic therapy. Am J Obstet Gynecol. 1988; 158: 1446–1453
   PubMed Web of Science ®Google Scholar
• Musser DA, Fiel RJ. Cutaneous photosensitizing and immunosuppressive effects of a series of tumor localizing porphyrins. Photochem Photobiol. 1991; 53: 119–123
   PubMed Web of Science ®Google Scholar
• Winkelman J, Rasmussen-Taxdal DS. Quantitative determination of porphyrin uptake by tumor tissue following parenteral administration. Bull Johns Hopkins Hosp. 1960; 107: 228–233
   PubMedGoogle Scholar
• Rasmussen-Taxdal DS, Ward GE, Figge FH. Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Cancer 1955; 8: 78–81
   PubMed Web of Science ®Google Scholar
• Lipson RL, Baldes EJ, Olsen AM. The use of a derivative of haematoporphyrin in tumor detection. J Natl Cancer Inst. 1961; 26: 1–11
   PubMed Web of Science ®Google Scholar
• Lipson RL, Baldes EJ, Olsen AM. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant diseases. J Thorac Cardiovasc Surg. 1961; 42: 623–629
   PubMed Web of Science ®Google Scholar
• Lipson RL, Baldes EJ, Olsen AM. Hematoporphyrin derivative for detection and management of cancer. Proc IX Int Cancer Congr. 1966; 393
   Google Scholar
• Gregorie HG, Horger EO, Ward JL, et al. Hematoporphyrin derivative fluorescence in malignant neoplasms. Ann Surg. 1968; 167: 820–828
   PubMed Web of Science ®Google Scholar
• Dougherty TJ, Grindey GB, Fiel KR, Weishaupt KR, Boyle DG. Photoradiation therapy, II: cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst. 1975; 55: 115–121
   PubMedGoogle Scholar
• Tsutsui M, Carrano C, Sutsui EA. Tumor localizers: porphyrins and related compounds (unusual metalloporphyrins XIII). Ann NY Acad Sci. 1975; 244: 674–684
   PubMed Web of Science ®Google Scholar
• Atlante A, Moreno G, Passarella S, Salet C. Hematoporphyrin derivative (Photofrin II) photosensitization of isolated mitochondria: impairment of anion translocation. Biochem Biophys Res Commun. 1986; 141: 584–590
   PubMedGoogle Scholar
• Dubbelman TMAR, van Steveninck J. Photodynamic effect of hematoporphyrin derivative on transmembrane transport system of murine L929 fibroblasts. Biochim Biophys Acta. 1984; 771: 201–207
   PubMed Web of Science ®Google Scholar
• Hilf R, Smail DB, Murant RS, Leake PB, Gibson SL. Hematoporphyrin derivative-induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R3230 AC mammary adenocarcinomas of rats. Cancer Res. 1984; 44: 1483–1488
   PubMed Web of Science ®Google Scholar
• Gibson SL, Hilf R. Photosensitization of mitochondrial cytochrome c oxidase by hematoporphyrin derivative and related porphyrins in vitro and in vivo. Cancer Res. 1983; 43: 4191–4197
   PubMed Web of Science ®Google Scholar
• Perlin DS, Murant RS, Gibson SL, Hilf R. Effects of photosensitization by hematoporphyrin derivative on mitochondrial triphosphate-mediated proton transport and membrane integrity of R3230 AC mammary adenocarcinoma. Cancer Res. 1985; 45: 653–658
   PubMed Web of Science ®Google Scholar
• Ceckler TL, Bryant RC, Penney DP, Gibson SL, Hilf R. 31P-NMR spectroscopy demonstrates decreased ATP levels in vivo as an early response to photodynamic therapy. Biochem Biophys Res Commun. 1986; 140: 273–279
   PubMedGoogle Scholar
• Hilf R, Gibson SL, Penney DP, Ceckler TL, Bryant RG. Early biochemical response to photodynamic therapy monitored by NMR spectroscopy. Photochem Photobiol. 1987; 46: 809–817
   PubMedGoogle Scholar
• Fingar VH, Wieman TJ, Karavolos PS. The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response. Photochem Photobiol. 1993; 58: 251–258
   PubMedGoogle Scholar
• Hampton JA, Selman SH. Mechanisms of cell killing in photodynamic therapy using a novel in vivo drug/in vitro light culture system. Photochem Photobiol. 1992; 56: 235–243
   PubMedGoogle Scholar
• Peng Q, Moan J, Kongshaug M, Evensen JF, Anholt H, Rimington C. Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin II and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor. Int J Cancer 1991; 48: 258–264
   PubMedGoogle Scholar
• Peng Q, Moan J, Cheng LS, Nesland JM., Rimington C. Potential photosensitizer for photochemotherapy of cancer: uptake and localization of disulfonated aluminum phthalocyanine (AIPcS2) in mice bearing a human malignant tumor. Lasers Life Sci. 1993; 5: 175–184
   Google Scholar
• Peng Q, Moan J, Cheng LS. The effect of glucose administration on the uptake of Photofrin II in a human tumor xenograft. Cancer Lett. 1991; 58: 29–35
   PubMed Web of Science ®Google Scholar
• Peng Q, Moan J, Farrants GW, Danielsen HE, Rimington C. Location of PII and AIPcS4 in human tumor LOX in vitro and in vivo by means of computer-enhanced video fluorescence microscopy. Cancer Lett. 1991; 58: 37–47
   PubMedGoogle Scholar
• Peng Q, Brown SB, Moan J, et al. Biodistribution of a methylene blue derivative in tumor and normal tissue of rats. J. Photochem Photobiol B:Biol. 1993; 20: 63–71
   PubMedGoogle Scholar
• Peng Q, Ma LW, Berg K, Moan J. Effect of sulfonation on the photosensitizing efficiency of aluminum phthalocyanine and meso-tetraphenylporphine in photodynamic therapy of cancer. SPIE 1993; 2078: 258–267
   Google Scholar
• Peng Q, Nesland JM, Madslien K, Danielsen HE, Moan J. Subcellular photodynamic action sites of sulfonated aluminum phthalocyanines in a human melanoma cell line. SPIE 1996; 2628, in press
   Google Scholar
• Peng Q. 1985, Unpublished data.
   Google Scholar
• Detty MR, Merkel PB, Hilf R, Gibson SL, Powers SK. Chalcogenapyrylium dyes as photochemotherapeutic agents: tumor uptake, mitochondrial targeting and singlet-oxygen-induced inhibition of cytochrome c oxidase. J Med Chem. 1990; 33: 1108–1116
   PubMed Web of Science ®Google Scholar
• Malik Z, Chitayat SD, Langzam Y. Hemin dependent morphological maturation and endogenous porphyrin synthesis by K562 leukemic cells. Cancer Lett. 1988; 41: 203–209
   PubMedGoogle Scholar
• Shulok JR, Klaunig JE, Selman SH, Schafer PJ, Goldblatt PJ. Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells. Am J Pathol. 1986; 122: 277–283
   PubMedGoogle Scholar
• Davies CdeL, Ranheim T, Malik Z, Rofstad EK, Moan J, Lindmo T. Relationship between changes in antigen expression and protein synthesis in human melanoma cells after hyperthermia and photodynamic treatment. Br J Cancer 1988; 58: 306–313
   PubMedGoogle Scholar
• Evensen JF, Malik Z, Moan J. Ultrastructural changes in the nuclei of human carcinoma cells after photodynamic treatment with hematoporphyrin derivative and tetrasodium-meso-tetra(4-sulphonatophenyl)porphine. Lasers Med Sci. 1988; 3: 195–206
   Google Scholar
• Deng YH, Liang H. Scanning electron microscopic observation on photodynamic effects in cells in vitro. Lasers Med Sci. 1990; 5: 375–379
   Google Scholar
• Yu DS, Chang SY, Ma CP. Ultrastructural changes of bladder cancer cells following methylene blue-sensitized photodynamic treatment. Eur Urol. 1991; 19: 322–326
   PubMed Web of Science ®Google Scholar
• Roberts WG, Liaw LH, Berns MW. An electron microscopy study of cellular destruction with mono-L-aspartyl chlorin e6 and photofrin II. Lasers Surg Med. 1989; 9: 102–108
   PubMed Web of Science ®Google Scholar
• He XY, Sikes RA, Thomsen S, Chung LWK, Jacques SL. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines. Photochem Photobiol. 1994; 59: 468–473
   PubMed Web of Science ®Google Scholar
• Miller K, Reich E, Ruck A, Hautmann R. Photodynamic therapy of bladder cancer: uptake and phototoxicity of photosan in vitro. Urol Res. 1991; 19: 353–356
   PubMedGoogle Scholar
• Zaidi SIA, Oleinick NL, Tarif-Zaim M, Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem Photobiol. 1993; 58: 771–776
   PubMed Web of Science ®Google Scholar
• Tatsuta M, Iishi H, Yamamura H, Yamamoto R, Okuda S. Comparison of photodynamic inactivation of experimental stomach tumors sensitized by acridine orange or hematoporphyrin derivatives. Oncology 1988; 45: 35–40
   PubMedGoogle Scholar
• Schuitmaker JJ, Vrensen GF, van Delft JL, de Wolff-Rouendaal D, Dubbelman TM, de Wolf A. Morphologic effects of bacteriochlorin a and light in vivo on intraocular melanoma. Invest Ophthalmol Vis Sci. 1991; 32: 2683–2688
   PubMedGoogle Scholar
• Milanesi C, Biolo R, Jori G, Schaffner K. Experimental photodynamic therapy with tetrapropyl-porphycene: ultrastructural studies on the mechanism of tumor photo-damage. Lasers Med Sci. 1991; 6: 437–442
   Google Scholar
• Kato H, Aizawa K, Shinohara H, et al. Cytomorphological changes caused by hematoporphyrin derivative and photodynamic therapy. Lasers Life Sci. 1986; 1: 13–27
   Google Scholar
• Zhou CN, Xu BZ, Xie JG, et al. An ultrastructural study of human bladder cancer treated by photodynamic therapy. Lasers Med Sci. 1988; 3: 87–92
   Google Scholar
• Winther J, Ehlers N. Histopathological changes in an intraocular retinoblastoma-like tumor following photodynamic therapy. Acta Ophthalmol Copenh. 1988; 66: 69–78
   PubMedGoogle Scholar
• Milanesi C, Biolo R, Reddi E, Jori G. Ultrastructural studies on the mechanism of the photodynamic therapy of tumors. Photochem Photobiol. 1987; 46: 675–681
   PubMed Web of Science ®Google Scholar
• Warloe T, Peng Q, Heyerdahl H, Moan J, Steen HB, Giercksky K-E. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. 5th International Photodynamic Association Biennial Meeting, A. Cortese Denis. Proc. SPIE, 1995; 2371: 226–235
   Google Scholar
• Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-ami-nolevulinic acid. J Am Acad Dermatol. 1993; 28: 17–21
   PubMed Web of Science ®Google Scholar
• Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumors of the skin using topical 5-amino-levulinic acid sensitization and laser irradiation. Br J Dermatol. 1994; 130: 743–751
   PubMed Web of Science ®Google Scholar
• Loh CS, Bedwell J, MacRobert AJ, Krasner N, Phillips D, Bown SG. Photodynamic therapy of the normal rat stomach: a comparative study between disulphonated aluminum phthalocyanine and 5-aminolevulinic acid. Br J Cancer 1992; 66: 452–462
   PubMedGoogle Scholar
• Loh CS, MacRobert AJ, Regula J, Bown SG. Oral vs i.v. administration of 5-ALA. Br J Cancer 1993; 68: 41–51
   PubMed Web of Science ®Google Scholar
• Grant WE, Hopper C, MacRobert AJ, Speight PM, Bown SG. Photodynamic therapy of oral cancer:photosensitization with systemic aminolevulinic acid. Lancet 1993; 342: 147–148
   PubMed Web of Science ®Google Scholar
• Szeimies RM, Sassy T, Landthaler M. Penetration potency of topical applied 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol. 1994; 59: 73–76
   PubMed Web of Science ®Google Scholar
• Peng Q, Warloe T, Moan J, Steen H, Giercksky K-E, Nesland JM. (1993) Localization of ALA-induced porphyrins in normal and malignant tissues of mice, dogs and patients. Conference on photosensitization and photochemotherapy of cancer. 16–17 March, 1993. Oslo, S4, Abstract book
   Google Scholar
• Peng Q, Warloe T, Moan J, et al. Distribution of 5-amino-levulinic acid-induced porphyrins in nodulo-ulcerative basal cell carcinoma. 1995; 62: 906–913
   Google Scholar
• Krosl G, Korbelik M, Dougherty GJ. Induction of immune cell infiltration into murine SCCVII tumor by Photofrin-based photodynamic therapy. Br J Cancer 1995; 71: 549–555
   PubMed Web of Science ®Google Scholar
• Kvam E, Stokke T, Moan J. The lengths of DNA fragments light-induced in the presence of a photosensitizer localized at the nuclear membrane of human cells. Biochim Biophys Acta. 1990; 1049: 33–37
   PubMedGoogle Scholar
• Peng Q, Moan J, Ma LW, Nesland JM. Uptake, localization and photodynamic effect of meso-tetra(hydroxyphenyl)porphyrin and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Cancer Res. 1995; 55: 2620–2626
   PubMed Web of Science ®Google Scholar